Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TERN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TERN investment potential.

What is TERN stock price today?

Get real-time TERN stock price, historical data, and price charts on Financhill. Track TERN performance with our advanced analysis tools.

Is TERN a good investment?

Evaluate TERN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TERN stock?

To buy TERN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TERN?

View detailed market capitalization data and company valuation metrics for TERN on our comprehensive analysis page.

What is the P/E ratio of TERN?

Use our fundamental analysis tools to view TERN P/E ratio and compare valuation metrics with industry peers.

What are TERN earnings?

View TERN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Terns Pharmaceuticals, Inc. Stock Predictions

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

TERN
Terns Pharmaceuticals, Inc.

Last Price:

$35.46

Seasonality Move:

-26.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

Terns Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 155.4% based on the past 4 years of stock performance.
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Terns Pharmaceuticals, Inc. Stock Undervalued?

The current Terns Pharmaceuticals, Inc. [TERN] share price is $35.48. The Score for TERN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
TERN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Terns Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 155.4% based on the past 4 years of stock performance.

Terns Pharmaceuticals, Inc. Stock Rating

Sell

Terns Pharmaceuticals, Inc. (TERN) is a Sell

Is Terns Pharmaceuticals, Inc. overpriced?

Terns Pharmaceuticals, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Terns Pharmaceuticals, Inc. Stock Price History

Is TERN stock going to rise?

The current trend is moderately bearish and TERN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

ternspharma.com

52-Week Data

52-Week High:

48.26

52-Week Low:

1.87

Prediction Charts

Market Cap:

3.2B

Price in USD:

35.48

Volume:

3.5M

Beta:

-0.28

Technical Analysis

SMA50:

30.92

SMA100:

19.28

SMA200:

11.62

52-Wk Change:

576.45%

Stock Predictions

Is Terns Pharmaceuticals, Inc. stock public?

Yes, Terns Pharmaceuticals, Inc. is a publicly traded company.
What is the Terns Pharmaceuticals, Inc. stock quote today?

The Terns Pharmaceuticals, Inc. stock price is 35.48 USD today.
How to buy Terns Pharmaceuticals, Inc. stock online?

You can buy Terns Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-19	40.00	39.90	41.02	39.30
Dec-22	40.01	40.64	40.91	39.72
Dec-23	40.25	41.53	42.80	40.12
Dec-24	41.83	42.38	42.97	41.37
Dec-26	42.19	41.52	42.53	41.41
Dec-29	41.83	41.50	41.83	40.90
Dec-30	41.21	40.59	41.50	39.96
Dec-31	40.60	40.40	41.05	39.94
Jan-2	40.43	40.11	41.26	38.78
Jan-5	40.13	39.19	40.48	37.94
Jan-6	39.91	38.32	39.97	37.37
Jan-7	37.89	40.00	40.84	37.89
Jan-8	39.94	37.77	40.39	37.17
Jan-9	37.83	35.48	38.35	35.00

Terns Pharmaceuticals, Inc. Earnings

Terns Pharmaceuticals, Inc. Earnings Report: Per Share Terns Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Terns Pharmaceuticals, Inc. Forecast Revenue Growth

Terns Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Terns Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.23 per share.

* Terns Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.